Virtual Far-sight Reading Device for Pre-myopia in Children
Official title: A Randomized Controlled Clinical Trial on the Efficacy and Safety of the Virtual Far-sight Reading Device for Myopia Intervention in Pre-myopic Children
Run by Shanghai Eye Disease Prevention and Treatment Center · NCT06995911 · Data updated 2026-11-12
A device-guided reading program is tested to see if it can slow or prevent myopia in kids with pre-myopia and if it's safe with daily use for up to 6 months.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Years to 12 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Shanghai Eye Disease Prevention and Treatment Center Academic / other |
| Locations | 1 site (Shanghai) |
| Status | Recruiting |
| Started | June 1, 2025 |
| Main results expected | May 31, 2026 |
| Study ends | May 31, 2026 |
| Registry record updated | May 26, 2026 |
| Trial ID | NCT06995911 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 6–12 with very mild refractive error consistent with pre-myopia and a family history of myopia.
✕Probably not a fit
Children without pre-myopia or with ocular or systemic conditions excluding them from participation may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study tests a novel Virtual Far-sight Reading Device designed to simulate long-distance viewing during near-work to slow myopia progression in children aged 6–12 with pre-myopia. It uses a randomized, crossover design where participants switch between using the device and standard near-work after 90 days, with ophthalmic evaluations at baseline, day 90, and day 180. Outcomes focus on changes in refraction and eye health, along with safety and tolerability over time. Compliance, daily use, and potential eye discomfort are monitored, and free eye checkups are provided during the trial.
Why it matters
Potential benefit: If successful, the device could reduce the risk of myopia progression and offer a daily-friendly option to help at-risk children.
How similar studies have gone: Previous approaches using near-work modification and visual environment changes have shown mixed results; this study tests a novel device-based method with a crossover design.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Age: 6-12 years (inclusive), gender unrestricted.
* Worse eye cycloplegic spherical equivalent refraction (SER): -0.5 D \< SER ≤ +0.75 D; Cylinder ≤ -1.5 D in both eyes; Interocular anisometropia ≤ 1.5 D ③ Visual acuity: Best-corrected visual acuity (BCVA) ≤ 0.1 logMAR in both eyes. ④ Family history: At least one parent with myopia.
* Intraocular pressure (IOP): 10-21 mmHg in both eyes; Interocular IOP difference ≤ 5 mmHg
⑥ Compliance: Commitment to daily home use of the Far-Image Light Field Desk per protocol, immediate notification to investigators if unable to comply, and completion of scheduled follow-ups.
⑦ Informed consent: Signed assent form (minor) and written informed consent from legal guardian.
Exclusion Criteria:
* Ocular comorbidities affecting vision/refractive development: Marfan syndrome; Lens pathologies (e.g., cataracts); Glaucoma; retinal detachment; retinopathy of prematurity
* Systemic diseases: Immune/CNS disorders; Down syndrome; Severe cardiopulmonary/hepatic/renal dysfunction; Uncontrolled asthma
* Ocular abnormalities: Manifest strabismus; Binocular vision dysfunction; Pathological ocular changes or active ocular inflammation ④ Recent myopia interventions (within 3 months prior to screening): Orthokeratology; multifocal contact lenses; Functional spectacles, red-light therapy
⑤ Medications affecting efficacy evaluation (within 3 months): Anticholinergics (e.g., atropine, pirenzepine); Cholinergics (e.g., pilocarpine)
⑥ Participation in other clinical trials within 3 months.
⑦ Contraindications/allergies to cycloplegics or study-related medications.
⑧ Chronic psychiatric disorders or cognitive impairment.
⑨ Other conditions deemed unsuitable by investigators.
Where it's running
-
Shanghai Eye Disease Prevention and Treatment Center
Shanghai, China Recruiting
Study contacts
- Study coordinator: Wei Xu, Prof
- Email: vvxuwei@163.com
- Phone: +86 18521513008
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-assisted DIMS glasses to stop myopia in young children with pre-myopia
This trial tests whether AI-assisted DIMS-style glasses can help prevent myopia in children aged 3–6 who are at risk.
-
Preventing early childhood myopia with special spectacle lenses and low-dose atropine
This project will try spectacle lenses with highly aspherical lenslets and low-dose (0.01% and 0.05%) atropine eye drops to see if they slow myopia progression in children aged 3–6.
-
Evaluating a device for screening vision problems in young children
This study is testing a new device to see if it can effectively find vision problems in children aged 3 to 8, whether they wear glasses or not.
-
Optimizing light exposure to prevent and control myopia in children
This study tests if changing classroom lighting to mimic sunlight or using a smartphone app to guide light exposure can help prevent and control myopia in primary school children.
-
Hyperopic reserve screening for kindergartners in Beijing
A population-wide screening tests whether senior kindergarten children in Beijing have enough hyperopic reserve to help prevent future myopia.
-
Do dual-focus multifocal contact lenses improve hand-eye coordination and sports vision compared with your usual lenses
This study tests whether wearing dual-focus multifocal contact lenses improves hand-eye coordination and sports vision in adults who play baseball or softball and normally wear contact lenses.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.